Benefits
Supports Stomach Comfort
DGL has a long traditional use for supporting comfort after meals, helping ease occasional indigestion, fullness, and mild burning sensations associated with everyday dietary stressors.
Helps Maintain Gastric Mucosal Health
Licorice flavonoids may help maintain the protective mucus layer lining the stomach, supporting resilience of the gastric mucosa against irritants such as spicy foods, alcohol, and occasional NSAID use.
Avoids Glycyrrhizin-Related BP Effects
Because glycyrrhizin has been largely removed, DGL is preferred over whole licorice for longer-term use, helping users obtain the soothing properties of the herb without the pseudo-aldosteronism risk of regular licorice.
May Ease Functional Dyspepsia Symptoms
Flavonoid-rich G. glabra extracts have been evaluated in randomized trials of functional dyspepsia, where they helped support reductions in symptom severity scores compared with placebo over four weeks.
Mechanism of action
Mucus Secretion and Mucosal Coating
Licorice flavonoids appear to increase secretion of mucin and stimulate prostaglandin-like cytoprotective pathways in the gastric epithelium, providing a physical and chemical barrier over irritated mucosa.
Anti-Inflammatory Flavonoid Activity
Glabridin, liquiritigenin, and related flavonoids inhibit pro-inflammatory NF-κB signaling and modulate cytokines such as TNF-α and IL-6 in gastrointestinal mucosa preclinically.
Helicobacter pylori Modulation
In vitro and clinical work suggest licorice flavonoids can suppress H. pylori adhesion and growth, which may contribute to the symptomatic relief seen in functional dyspepsia.
Clinical trials
Randomized, double-blind, placebo-controlled trial; 75 mg flavonoid-rich G. glabra extract twice daily for 30 days
Adults with functional dyspepsia (Rome criteria)
Active extract was associated with significantly greater reductions in total symptom score and improvement in global efficacy assessment vs placebo, with good tolerability over the 30-day intervention.
Retrospective endoscopic survey; oral DGL tablets in patients with chronic duodenal ulcer
32 adult patients with endoscopically confirmed chronic duodenal ulcer
Endoscopic examination after a course of DGL showed ulcer healing in the surveyed group, with mucosa appearing largely normal at follow-up; an early, uncontrolled but historically informative observation supporting later RCT work.
Double-blind randomized trial of DGL vs placebo in gastric ulcer patients
Adults with endoscopically documented gastric ulcer
Early controlled trial work produced mixed results, with some DGL groups showing greater symptomatic relief and others showing no significant healing difference vs placebo, underscoring the need for adjunctive use rather than monotherapy.